Christopher Lima, Ph.D. – Keynote speaker, 2021 RNA Symposium

 


KEYNOTE SPEAKER 5: March 26, 2021, 12:10–1:05 pm

More information on the Symposium

Blog by MiSciWriters

“Mechanisms that target RNA for destruction”
Christopher D. Lima, Ph.D.
Alfred P. Sloan Chair; Chair and Member and Professor, Structural Biology Program, Sloan Kettering Institute; Investigator, Howard Hughes Medical Institute

The Christopher Lima Lab

TALK ABSTRACT
Decay and quality control pathways ensure that RNA is cleared from cells after it is used or if it is found to be aberrant or defective in function. One such pathway involves the RNA exosome, a multi-subunit exoribonuclease complex that contributes to nuclear RNA processing or decay through interactions with co-factors that bridge the RNA exosome to helicase-dependent processing complexes that prepare and present RNA substrates for processing and/or degradation. Results will be presented from ongoing biochemical and structural studies aimed at understanding how RNA exosome co-factors coordinate the activities of the RNA exosome in pathways that contribute to RNA quality control.

Keywords: RNA, RNA exosome, helicase, RBM7, NEXT complex, R-loop, RNA degradation, poly(A), poly(U)

Supported in part by HHMI and the National Institutes of Health (GM118080)

REFERENCES
Reviews:
Weick and Lima, Curr Opin Struct Bio (https://pubmed.ncbi.nlm.nih.gov/33147539/)
Puno et al., Cell (https://pubmed.ncbi.nlm.nih.gov/31539497/)

Papers:
Puno and Lima, PNAS (https://pubmed.ncbi.nlm.nih.gov/29844170/)
Weick et al., Cell (https://pubmed.ncbi.nlm.nih.gov/29906447/)

 

Similar Posts

  • 2020-2021 Seminars

    Read about our 2020-21 Seminar season here. Monday, June 14, 4:00 pm, Yousuf Khan, Stanford and Mike McMillan, University of Michigan – Link to recording Monday, May 17, 4:00 pm, Thomas Martinez, Salk Institute for Biological Studies Monday, May 3, 4:00 pm, Olivia Rissland, University of Colorado, Medical School Monday, April 19, 4:00 pm, Jailson…

  • 2023-2024 Seminars

    Up Next: The 2023-2024 RNA Innovative Seminar Series has concluded. Seminars will resume in September 2024, check back for updates! 2023 Monday, September 11, 4:00 pm, Graham Erwin, Stanford University Monday, September 25, 4:00 pm, Jeffrey Barrick, UT at AustinMonday, October 9, 4:00 pm, Guizhi (Julian) Zhu, University of MichiganMonday, October 23, 4:00 pm, Susan Gottesman,…

  • Brenda Bass, Ph.D. – Keynote speaker, 2021 RNA Symposium

      KEYNOTE SPEAKER 5: March 26, 2021, 11:05–12:00 pm More information on the Symposium Blog by MiSciWriters “Distinguishing self and non-self dsRNA in vertebrates and invertebrates” Brenda Bass, Ph.D. Distinguished Professor of Biochemistry University of Utah The Brenda Bass Lab Twitter: @BassLabUtah TALK ABSTRACT When a virus infects an animal cell, including a human cell,…

  • CRISPR to KLIPP cancer

    While most efforts involving CRISPR are focused on genome editing, the CRISPR machinery could also be used as a molecular weapon to slice up chromosomes of cancer cells. Research has shown that chromosomes may undergo a “catastrophic” event early in the process of carcinogenesis causing multiple breakages. While many cells die in such events, some…

  • U-M Researchers Collaborate on $3 Million Grant to Treat Rare Forms of Cystic Fibrosis

    Center RNA Therapeutics Director Michelle Hastings, and faculty members Rachel Niederer and Alexandra Piotrowski-Daspit address the need for new treatment strategies, and the subsequent barriers that must be overcome for success, by working together as an interdisciplinary team with unique expertise in CFTR physiology, designing RNA therapeutics, identifying targetable regulatory sequences, and developing engineered delivery…